MBCD decreased stemness in MDA-MB-231. by Ankit Sharma (578833)

“…(<b>E</b>) RT-PCR analysis was performed using total RNA and gene specific primers. Decreased levels of stemness markers CD44 and BMI1 were found in MBCD treated cells. …”

UCHL1 depletion decreases Wnt signaling activity. by Patricia C. Sanchez-Diaz (403746)

“…<p>Using a TCF-dependent TOPflash reporter assay, on average, a 70% reduction in the activity of the Wnt pathway was found in the UCHL1 KDs compared to controls. Relative to control cells the Wnt signaling activity in the SJ-GBM2 knockdowns was decrease to 0.26 ± 0.05 (KD1) and 0.28 ± 0.09 (KD2) and, to 0.24 ± 0.04 (KD1) and 0.34 ± 0.13 (KD2) in the case of SF188 knockdowns. …”

Epithelial-specific disruption of <i>Meis1</i> decreased epidermal stem cells. by Kazuhiro Okumura (566659)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

MSCs decrease oligodendrocyte death. by Justin D. Glenn (800439)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Rapamycin decreases Schwann cell markers, whereas statin induces Schwann cell markers. by Andrea Preitschopf (629851)

Blocking EPCR decreases tumor growth of human breast cancer cells. by Florence Schaffner (400916)

Subjects:

Decreased <i>Lxn</i> expression in stem/progenitor-enriched CD34+ cells in patients with leukemia and lymphoma. by Yi Liu (36759)

Decrease of membrane potential and increase of ROS production upon wortmannin treatment in AD-iPSCs. by Amir M. Hossini (114292)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

CS exposure decreases weights in the offspring. by Anja Vogelgesang (564585)

Subjects:

Near anoxia decreases expression of stemness-related markers. by Rohini L. Kadle (4919335)

Exposure to DFX leads to decreased cell numbers of endothelial cells after 72 hours. by Jessica Ratajczak (3391412)

“…<p>Cell numbers were monitored via Trypan Blue Exclusion, only 72 hours of DFX treatment resulted in a decreased cell count (n = 3). Control: culture medium containing 0.1% FBS. …”

Production of intracellular reactive oxygen species (ROS) in hESCs was decreased after NaF treatment. by Xin Fu (448766)

Overexpression of PDE7B increases stem cell fraction and accelerates in vivo tumor growth and decreases survival. by Michael D. Brooks (627532)

“…<p>(<b>A</b>) Frequency of clonogenic stem-like cells as determined by Extreme Limiting Dilution Assays (ELDA) with U87 cells expressing PDE7B (WT), catalytically inactive PDE7B (H217Q) or no vector control (U87GL). …”

<i>Nrf2</i> expression in <i>Hesr1</i>/<i>Hesr3</i>-double null primary myoblasts is decreased. by Masahiko Yamaguchi (801411)

<i>Zscan10</i> mutant females show decreased body weight. by Petra Kraus (190913)

SN09-2 decreases mitochondrial membrane potential and induces ROS generation. by Sumi Park (420314)

Decreased lysosomal function. by Shuyan Lu (488931)